Security key
17322U306
Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR)
CUSIP: 17322U306
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 1,360,560
- Total 13F value
- $823,009
- Share change
- +363,640
- SEC-reported price per share
- $0.60
- Number of holders
- 43
- Value change
- +$199,557
- Number of buys
- 21
- Number of sells
- 17
- Shares outstanding
- 30,389,182
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
43
Top holders
10
CTXR full security history
Ownership snapshot
Full 13F holder table
Citius Pharmaceuticals, Inc. SEC filings
Citius Pharmaceuticals, Inc. company facts
Citius Pharmaceuticals, Inc. 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of CTXR - Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CVI Investments, Inc.
Disclosed value leader
CVI Investments, Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: CVI Investments, Inc.
Showing 1-6 of 15 holder rows.
Quick read
CVI Investments, Inc. leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens CVI Investments, Inc.'s linked filing trail.
Comparable ownership
Top 5
CVI Investments, Inc.
9.9%
GEODE CAPITAL MANAGEMENT, LLC
0.81%
VANGUARD CAPITAL MANAGEMENT LLC
0.55%
VANGUARD FIDUCIARY TRUST CO
0.26%
BlackRock, Inc.
0.23%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CVI Investments, Inc. |
13D/G
|
9.9%
|
$1,624,606
3,008,529 shares
|
+$331,454 | 30 Jun 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.81%
|
$221,556
246,158 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
0.55%
|
$150,964
167,738 shares
|
— | 31 Mar 2026 |
| VANGUARD FIDUCIARY TRUST CO |
13F
Company
|
0.26%
|
$69,980
77,755 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
Company
|
0.23%
|
$62,866
69,851 shares
|
— | 31 Mar 2026 |
| HRT FINANCIAL LP |
13F
Company
|
0.2%
|
$54,000
60,332 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
43
Shares
1,360,560
Rows available
43
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
38
Q2 2026 holders
43
Holder diff
5
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|